Why Inspire Medical Systems (INSP) Stock Is Trading Up Today

What Happened?

Shares of medical technology company Inspire Medical Systems (NYSE:INSP) jumped 3.3% in the morning session after the stock extended its positive momentum as a recent announcement of a $200 million share repurchase program boosted investor confidence. This buyback program, authorized by the company's board, suggests that management believes the stock is undervalued and is a way to signal their commitment to returning value to shareholders despite the recent operational challenges and revised financial guidance.

After the initial pop the shares cooled down to $87.91, up 3.9% from previous close.

Is now the time to buy Inspire Medical Systems? Access our full analysis report here, it’s free.

What Is The Market Telling Us

Inspire Medical Systems’s shares are extremely volatile and have had 31 moves greater than 5% over the last year. In that context, today’s move indicates the market considers this news meaningful but not something that would fundamentally change its perception of the business.

The previous big move we wrote about was 2 days ago when the stock gained 4% on the news that its Board of Directors announced a share buyback program of up to $200 million. Share buyback programs are often a sign that a company's leadership believes its stock is undervalued. This sentiment was echoed by CEO Tim Herbert, who stated, “we remain confident that our growth prospects are substantial… and that our stock is undervalued.” The plan authorizes the company to repurchase up to 8.6% of its shares. This announcement comes after the stock price declined following its recent second-quarter earnings report, suggesting management views the current price as an attractive investment. Adding to the positive momentum, the broader market also rallied on favorable inflation data, which may have provided an additional tailwind for the stock.

Inspire Medical Systems is down 53.5% since the beginning of the year, and at $87.91 per share, it is trading 59.4% below its 52-week high of $216.71 from September 2024. Investors who bought $1,000 worth of Inspire Medical Systems’s shares 5 years ago would now be looking at an investment worth $818.72.

Unless you’ve been living under a rock, it should be obvious by now that generative AI is going to have a huge impact on how large corporations do business. While Nvidia and AMD are trading close to all-time highs, we prefer a lesser-known (but still profitable) semiconductor stock benefiting from the rise of AI. Click here to access our free report on our favorite semiconductor growth story.

View Comments